OCUP שווי כולל של נכסי החברה Ocuphire Pharma Inc

Ocuphire Pharma, Inc. (OCUP) operates in the US, ensuring its scientific developments are shielded from external political conflicts and trade restrictions. Ocuphire Pharma, Inc. (OCUP) is implementing AI and robotics to accelerate the discovery of new molecules, minimizing manual labor in laboratories. This price chart reflects total assets at 44.16, although international sanctions and logistical complexities could slow the global launch of its drugs.

Total assets, reverse-calculated via ROA, combine equity and liabilities to assess the resource base, allowing an investor to determine the issuer's financial strength relative to competitors through the total asset value; the current 44.16 metric reflects the scale of tangible and intangible resources of Ocuphire Pharma, Inc. (OCUP), including small molecule patents that provide business protection in the race for retinal therapy.